In a National Institutes of Health (NIH) supported observational study, the University of Alabama at Birmingham (UAB) revealed that patients […]
The University of Florida won a $2.3 million grant in its quest to investigate liver scarring and inflammation triggered by […]
University of Tennessee (UT) Health Science Center Memphis investigators secured $2 million to pursue their potentially breakthrough diabetes research. The […]
Clinical Trials Research, a clinical investigational site in the Sacramento, CA area recently saved the life of a man on […]
Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. […]
WellCare of Georgia, a WellCare Health Plans, Inc. company (WCG), recently partnered with Fitbit to improve health and manage diabetes […]
With growth in India’s economy and middle class has come new diseases heretofore not that pervasive in India, such as […]
Industry Sponsor-funded real-world study called EMPagliflozin comparative effectiveness and SafEty (EMPRISE) reveals that empagliflozin was associated with a decreased risk […]
The University of Kansas Alzheimer’s Disease Center (KU ADC) and AstraZeneca have partnered to conduct a study to attempt to […]
A Virta Health pilot study reveals that 84% of veteran patients on the Virta Treatment for 90 days achieved glycemic […]
